药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Marimastat
Isopropamide
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.
Marimastat
Pipecuronium
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Pipecuronium.
Marimastat
Pancuronium
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.
Marimastat
Diphenidol
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Diphenidol.
Marimastat
Flavoxate
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.
Marimastat
Glycopyrronium
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.
Marimastat
Cycrimine
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Cycrimine.
Marimastat
Methantheline
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Methantheline.
Marimastat
Dicyclomine
Bupropion may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Marimastat
Alaproclate
The risk or severity of adverse effects can be increased when Bupropion is combined with Alaproclate.
Marimastat
Ritanserin
The risk or severity of adverse effects can be increased when Bupropion is combined with Ritanserin.
Marimastat
Indalpine
The risk or severity of adverse effects can be increased when Bupropion is combined with Indalpine.
Marimastat
Milnacipran
The risk or severity of adverse effects can be increased when Bupropion is combined with Milnacipran.
Marimastat
Sibutramine
The risk or severity of adverse effects can be increased when Sibutramine is combined with Bupropion.
Marimastat
Seproxetine
The risk or severity of adverse effects can be increased when Bupropion is combined with Seproxetine.
Marimastat
Zimelidine
The risk or severity of adverse effects can be increased when Bupropion is combined with Zimelidine.
Marimastat
Vortioxetine
The risk or severity of adverse effects can be increased when Bupropion is combined with Vortioxetine.
Marimastat
Ioflupane I-123
Bupropion may decrease effectiveness of Ioflupane I-123 as a diagnostic agent.
Marimastat
(S)-Warfarin
The risk or severity of adverse effects can be increased when Bupropion is combined with (S)-Warfarin.
Marimastat
(R)-warfarin
The risk or severity of adverse effects can be increased when Bupropion is combined with (R)-warfarin.